-
1
المؤلفون: Autumn J. McRee, Takayuki Yoshino, Filip de Vos, Chloe E. Atreya, Eduard Gasal, Jan H.M. Schellens, Salvatore Siena, Eric Van Cutsem, Rona Yaeger, Thierry André, John Millholland, Ryan B. Corcoran, Antoine Hollebecque, Catarina D. Campbell, Josep Tabernero, Peter J. O'Dwyer, Fatima Rangwala, Johanna C. Bendell, Jan C. Brase, Yiqun Yang, Gary Middleton, Michael S. Gordon
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 11
مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Pyridones, Colorectal cancer, medicine.medical_treatment, Oncology and Carcinogenesis, MAP Kinase Kinase 1, Context (language use), Pyrimidinones, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Clinical Research, Internal medicine, Oximes, Antineoplastic Combined Chemotherapy Protocols, Genetics, medicine, Humans, Panitumumab, Oncology & Carcinogenesis, Cancer, Trametinib, Neoplastic, Tumor, business.industry, Imidazoles, Dabrafenib, Cell cycle, Prognosis, medicine.disease, Colo-Rectal Cancer, Survival Rate, ErbB Receptors, 030104 developmental biology, Gene Expression Regulation, 030220 oncology & carcinogenesis, Mutation, Colorectal Neoplasms, Digestive Diseases, business, Biomarkers, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52e5cb3b4371671e49f322da9c51f33Test
https://doi.org/10.1158/1078-0432.ccr-19-3579Test -
2
المؤلفون: Eva Ciruelos, Patricia Galván, Tomás Pascual, D. Martinez, José Baselga, Maria Vidal, Yuan Cheng, Laia Paré, Jan C. Brase, Gabriel N. Hortobagyi, Aleix Prat, Paolo Nuciforo, Barbara Adamo
المصدر: The Oncologist. 24:893-900
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, Breast Neoplasms, Placebo, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Double-Blind Method, Exemestane, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Breast Cancer, Biomarkers, Tumor, medicine, Humans, Everolimus, skin and connective tissue diseases, Aged, Retrospective Studies, business.industry, Proportional hazards model, Hazard ratio, International Agencies, Cancer, Middle Aged, Prognosis, medicine.disease, Androstadienes, Survival Rate, 030104 developmental biology, Receptors, Estrogen, chemistry, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Receptors, Progesterone, business, Follow-Up Studies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b73ccd3e24343a4ea055637ae57712aTest
https://doi.org/10.1634/theoncologist.2018-0407Test -
3
المؤلفون: Matthew Squires, Victoria Atkinson, Eduard Gasal, James Larkin, Richard F. Kefford, James Garrett, Axel Hauschild, Daniel Gusenleitner, Vanna Chiarion-Sileni, Caroline Robert, John M. Kirkwood, Jan C. Brase, Catarina D. Campbell, Mario Mandalà, Dirk Schadendorf, Reinhard Dummer, Mario Santinami, Georgina V. Long, Keith T. Flaherty
المساهمون: University of Zurich, Dummer, Reinhard
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Salvage therapy, 610 Medicine & health, Placebo, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Medicine, Survival rate, Trametinib, business.industry, 10177 Dermatology Clinic, Dabrafenib, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Biomarker (medicine), 2730 Oncology, business, medicine.drug
وصف الملف: 841_Dummer_R._et_al._Adjuvant_dabrafenib_plus_trametinib_versus_placebo_in_patients_with_resected,_BRAFV600_mutant,_stage_III_melanoma_etc_Lancet_Oncology_2020.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8deeff612b475730ab4040608e0e18baTest
https://www.zora.uzh.ch/id/eprint/187679Test/ -
4
المؤلفون: Aranzazu Fernandez-Martinez, Barbara Adamo, Blanca Gonzalez-Farre, Lisa A. Carey, Francesco Schettini, Benedetta Conte, Charles M. Perou, Jamunarani Veeraraghavan, Jan C. Brase, Sabino De Placido, Tomás Pascual, Mariavittoria Locci, Pierfranco Conte, Patricia Villagrasa, Montserrat Muñoz, Sonia Pernas, Fara Brasó-Maristany, Olga Martínez, Patricia Galván, Maria Vidal, Mothaffar F. Rimawi, C. Kent Osborne, Carla Rognoni, Gaia Griguolo, Rachel Schiff, Nuria Chic, Valentina Guarneri, Aleix Prat
المساهمون: Schettini, F., Pascual, T., Conte, B., Chic, N., Braso-Maristany, F., Galvan, P., Martinez, O., Adamo, B., Vidal, M., Munoz, M., Fernandez-Martinez, A., Rognoni, C., Griguolo, G., Guarneri, V., Conte, P. F., Locci, M., Brase, J. C., Gonzalez-Farre, B., Villagrasa, P., De Placido, S., Schiff, R., Veeraraghavan, J., Rimawi, M. F., Osborne, C. K., Pernas, S., Perou, C. M., Carey, L. A., Prat, A.
المصدر: Cancer Treat Rev
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, BIOMARKER, BREAST CANCER, HER2-ENRICHED, HER2-POSITIVE, PAM50, PATHOLOGIC COMPLETE RESPONSE, Receptor, ErbB-2, medicine.medical_treatment, Breast Neoplasms, Disease, Article, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, ErbB-2, Internal medicine, Pathologic complete response, medicine, Biomarkers, Tumor, Humans, Radiology, Nuclear Medicine and imaging, PAM50, skin and connective tissue diseases, neoplasms, Neoadjuvant therapy, Neoplasm Staging, Chemotherapy, Tumor, business.industry, Remission Induction, Biomarker, HER2-Enriched, HER2-positive, Female, Neoadjuvant Therapy, General Medicine, Odds ratio, medicine.disease, Genomic Biomarker, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, Biomarker (medicine), business, Biomarkers, Receptor
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::456360a8625da925d93580bf31f87b0fTest
https://europepmc.org/articles/PMC7230134Test/ -
5
المؤلفون: Eduard Gasal, Paul Nathan, Antoni Ribas, Neha Pakhle, Victoria Atkinson, Céleste Lebbé, Dirk Schadendorf, Mario Mandalà, Daniel Gusenleitner, Paolo A. Ascierto, Aisha Masood, Erika Richtig, Catarina D. Campbell, Reinhard Dummer, Ana Arance, Keith T. Flaherty, Hussein Abdul-Hassan Tawbi, Naoya Yamazaki, Georgina V. Long, Caroline Robert, Jan C. Brase
المساهمون: University of Zurich, Dummer, Reinhard
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Skin Neoplasms, Medizin, Cohort Studies, 0302 clinical medicine, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, Oximes, Clinical endpoint, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Melanoma, Trametinib, MEK inhibitor, Imidazoles, 10177 Dermatology Clinic, General Medicine, Middle Aged, MAP Kinase Kinase Kinases, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Biomarker (medicine), Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, Mutation, Missense, 610 Medicine & health, Genetics and Molecular Biology, Pyrimidinones, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Young Adult, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Biomarkers, Tumor, Humans, Protein Kinase Inhibitors, Aged, business.industry, Dabrafenib, medicine.disease, Clinical trial, Regimen, 030104 developmental biology, General Biochemistry, business
وصف الملف: 870_Dummer_R._et_al._Combined_PD-1,_BRAF_and_MEK_inhibition_in_advanced_BRAF-mutant_melanoma_Nature_Medicine_2020.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b17ee96d80a3281cdd7448c58c9110fTest
https://www.ncbi.nlm.nih.gov/pubmed/33020648Test -
6
المؤلفون: Jean-Jacques Grob, Mahrukh M. Syeda, Antoni Ribas, Georgina V. Long, Mahtab Marker, Broderick Corless, Dirk Schadendorf, Keith T. Flaherty, James Garrett, David Polsky, Eduard Gasal, Matthew Squires, Caroline Robert, Jan C. Brase, Jennifer M. Wiggins, Michael A. Davies, Paul Nathan
المصدر: Lancet Oncol
The Lancet. Oncology, vol 22, iss 3مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Mutant, Medizin, Phases of clinical research, Bioinformatics, Circulating Tumor DNA, 0302 clinical medicine, Oximes, Antineoplastic Combined Chemotherapy Protocols, Medicine, Melanoma, Cancer, Trametinib, screening and diagnosis, Brain Neoplasms, MEK inhibitor, Hazard ratio, Imidazoles, Middle Aged, Prognosis, Survival Rate, Detection, 030220 oncology & carcinogenesis, Female, 4.2 Evaluation of markers and technologies, medicine.drug, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, MEDLINE, Pyrimidinones, Article, 03 medical and health sciences, Text mining, Double-Blind Method, Clinical Research, Internal medicine, Humans, Oncology & Carcinogenesis, Survival rate, Aged, Performance status, business.industry, Dabrafenib, medicine.disease, Good Health and Well Being, 030104 developmental biology, Cancer genetics, business, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c3f1a9278111f2f965a594f4bbb278Test
https://doi.org/10.1038/s41571-021-00494-0Test -
7
المؤلفون: Maurizio Voi, Juan W. Valle, W. W. de Herder, D. Smith, Lida Bubuteishvili-Pacaud, Marianne Pavel, Matthew H. Kulke, Jan C. Brase, C. Lombard-Bohas, James C. Yao, R. Salazar, Evgeny Degtyarev, R. P. Riechelmann, Ivan Borbath, Philippe Ruszniewski, Nicola Fazio, E. Van Cutsem, Jaume Capdevila
المساهمون: Internal Medicine
المصدر: Ann Oncol
Kulke, M H, Ruszniewski, P, Van Cutsem, E, Lombard-Bohas, C, Valle, J, De Herder, W W, Pavel, M, Degtyareva, E, Brase, J C, Pacaud, L B, Voi, M, Salazar, R, Borbath, I, Fazio, N, Smith, D, Capdevila, J, Riechelmann, R P & Yao, J C 2017, ' A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors : COOPERATE-2 trial ', Annals of Oncology, vol. 28, no. 6, mdx078 . https://doi.org/10.1093/annonc/mdx078Test
Annals of Oncology, 28(6), 1309-1315. Elsevier Ltd.مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Phases of clinical research, Neuroendocrine tumors, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Everolimus, Progression-free survival, Adverse effect, GASTROINTESTINAL TUMOR, Aged, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Hazard ratio, Hematology, Middle Aged, medicine.disease, Survival Analysis, Corrigenda, Pasireotide, Pancreatic Neoplasms, Neuroendocrine Tumors, 030104 developmental biology, Endocrinology, chemistry, 030220 oncology & carcinogenesis, Disease Progression, Female, Somatostatin, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a731598e62b38701a6cb1e632c0a43Test
https://pure.eur.nl/en/publications/d82d3862-955a-415f-8cfc-2d09cb8cfa0cTest -
8
المؤلفون: Gary Middleton, A. Scott Jung, Fatima Rangwala, Kei Muro, Takayuki Yoshino, Salvatore Siena, Ryan B. Corcoran, Eric Van Cutsem, Savina Jaeger, Michael S. Gordon, Thierry André, Jan C. Brase, Josep Tabernero, Autumn J. McRee, Yves Humblet, Filip de Vos, Jan H.M. Schellens, Peter J. O'Dwyer, Antoine Hollebecque, Johanna C. Bendell, Chloe E. Atreya, Severine Bettinger, Rona Yaeger, Bijoyesh Mookerjee
المصدر: Cancer discovery, vol 8, iss 4
مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Neuroblastoma RAS viral oncogene homolog, Male, Proto-Oncogene Proteins B-raf, endocrine system diseases, Colorectal cancer, Pyridones, MAP Kinase Signaling System, Oncology and Carcinogenesis, Drug Resistance, Pyrimidinones, medicine.disease_cause, Article, 03 medical and health sciences, 0302 clinical medicine, Oximes, Antineoplastic Combined Chemotherapy Protocols, medicine, Panitumumab, Humans, Protein Kinase Inhibitors, neoplasms, Cancer, Trametinib, Mitogen-Activated Protein Kinase Kinases, business.industry, Melanoma, Imidazoles, Dabrafenib, medicine.disease, digestive system diseases, Colo-Rectal Cancer, ErbB Receptors, 030104 developmental biology, Good Health and Well Being, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Cancer research, Neoplasm, Female, KRAS, business, Digestive Diseases, Colorectal Neoplasms, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6e0d56b6f338dad6ec8c261085103dTest
https://europepmc.org/articles/PMC5882509Test/ -
9
المؤلفون: E. Martínez, Begoña Bermejo, Laia Paré, Luis Manso, Jan C. Brase, Sonia Pernas, Paolo Nuciforo, I Garau, N. Martínez, Ramon Lopez, Esther Holgado, Maria Vidal, Montse Muñoz, Mafalda Oliveira, J. Cortés, Roberta Fasani, Vanessa Rodrik-Outmezguine, Patricia Villagrasa, Antonio Llombart-Cussac, Aleix Prat, Patricia Galván, J. Alarcón, Tomás Pascual
المصدر: ANNALS OF ONCOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Annals of oncology : official journal of the European Society for Medical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-FISABIO. Repositorio Institucional de Producción Científicaمصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Receptor, ErbB-2, Breast Neoplasms, chemical and pharmacologic phenomena, Lapatinib, Models, Biological, 03 medical and health sciences, pathologic complete response, 0302 clinical medicine, Breast cancer, Clinical Trials, Phase II as Topic, Lymphocytes, Tumor-Infiltrating, breast cancer, Trastuzumab, Predictive Value of Tests, Internal medicine, HER2, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multicenter Studies as Topic, skin and connective tissue diseases, Aged, Randomized Controlled Trials as Topic, Univariate analysis, tumor-infiltrating lymphocytes (TILs), Models, Statistical, business.industry, Tumor-infiltrating lymphocytes, Cancer, hemic and immune systems, Hematology, Middle Aged, medicine.disease, Chemotherapy regimen, Neoadjuvant Therapy, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Hormonal therapy, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777630da6ab858b8fdab3b527a5bf299Test
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2996Test -
10
المؤلفون: Y. Cheng, Maria Vidal, Patricia Galván, Aleix Prat, Laia Paré, Eva Ciruelos, D. Martinez, B. Adamo, T. Pascual, Gabriel N. Hortobagyi, J. Baselga, Jan C. Brase, Paolo Nuciforo
المصدر: European Journal of Cancer. 92:S117-S118
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Everolimus, business.industry, Advanced breast, Cancer, Placebo, medicine.disease, 03 medical and health sciences, chemistry.chemical_compound, 030104 developmental biology, 0302 clinical medicine, Oncology, Exemestane, chemistry, Hormone receptor, 030220 oncology & carcinogenesis, Cancer research, Medicine, business, Human Epidermal Growth Factor Receptor 2, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9655bcb0a2995c5a8cc39098ff989ec8Test
https://doi.org/10.1016/s0959-8049Test(18)30574-4